American Century Companies’s ARS Pharmaceuticals SPRY Stock Holding History

American Century Companies's SPRY Position: Q2 2026 in Review

American Century Companies reduced its ARS Pharmaceuticals (SPRY) stake by 97% in Q2 2026, selling an estimated $3.59M and leaving 11,498 shares worth $92.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2839.

American Century Companies first reported a position in SPRY in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.31M in Q4 2025. 209 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

• American Century Companies held 11,498 shares of ARS Pharmaceuticals worth $92.1K as of Q2 2026.
• American Century Companies sold 417,101 ARS Pharmaceuticals shares in Q2 2026, an estimated $3.59M.
• ARS Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2839 holding.
• American Century Companies first reported a position in ARS Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
• American Century Companies's ARS Pharmaceuticals position peaked at $5.31M in Q4 2025.
• 209 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.